(3-(Piperidin-1-ylsulfonyl)phenyl)boronic acid, 98.0%, 1g

5-Bromo-2-methylpyridin-3-amine, 97.0%, 100g

Naftaleno, mínimo 99%, para síntesis, 100 g, envase de plástico.

PROPARGYL-PEG5-ACID, 95.0%, 100mg

2-(2-Chlorophenyl)piperidine, HCl, 95+%, 250mg

Z-Ser(Bzl)-OH, 95%, 25g

6-Chloro-3,4-dimethoxypyridazine, 95%, 1g

(2S,3S)-2,3-BIS(METHOXYMETHOXY)BUTANE-1,4-DIOL, 90.0%, 1g

2-Nitrophenylhydrazine hydrochloride, 98.0%, 1g

METHYL (S)-(+)-4,5-DIHYDRO-2-PHENYL-4-OXAZOLECARBOXYLATE, 95.0%, 250mg

Linsitinib, 250mg

TRANS-3-AMINO-2,2-DIMETHYLCYCLOBUTANOL HCL, 95.0%, 500mg

2-Methylbenzimidamide hydrochloride, 95.0%, 1g